This hasnt happened yet folks, LOLOL
BioAdaptives, Inc. Announces Intention to Spin off Its Livestock Impact Division as a Wholly-owned Subsidiary With Further Expansion in Botanical Drug Development and Animal Health Markets
8:00 am ET April 20, 2023 (Globe Newswire) Print
GlobeNewswireApril 20, 2023
LAS VEGAS, NV, April 20, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - BioAdaptives, Inc. (OTCMkts: BDPT) announced today the intention to spin off its Livestock Impact Division as a wholly-owned subsidiary. The new company will continue to develop and market natural supplements for performance animals and pets, but will expand its activities globally to include botanical drugs for both veterinary and human use.
According to Straits Research, "The global botanical drug market size was valued at USD 163 million in 2021 and is expected to be valued at USD 3221 million by 2030. The market is expected to grow at a CAGR of 39% during the forecast period -2022 to 2030. Further, the presence of favorable regulatory scenarios in some prominent countries like India, Australia, and South Korea has created a growth opportunity for The Global Botanical Drugs Market. The governments of the various developed and developing countries have undertaken initiatives to promote and support the development of natural drugs, which has increased the availability of the same in the different healthcare systems globally. Countries like Australia, South Korea, Nigeria, and India, have constantly been promoting the utilization of natural resources and substances for the treatment and curing of chronic diseases. The World Health Organization also advocates the usage of botanical drugs by investing largely in its research and developments."
Edward Jacobs, M.D.,CEO BioAdaptives, Inc., comments, "The strategic recent additions of Dr. Yaguang Liu, LY Research, and Dr. David Allen, President of the American Botanical Drug Association to our Board of Directors, significantly increases our ability to explore the global opportunity related to botanical drugs. As a holder of 32 patents and a renowned botanical drug expert, Dr. Liu can provide key scientific insight in this emerging market. Dr. Allen's intimate knowledge of global supplements and botanical drug markets greatly enhances our ability to achieve our goals. We anticipate that the experienced leadership of both Dr. Liu and Dr. David Allen, will be especially beneficial in accelerating the progress of the new Livestock Impact entity."
